Mold-Tek Technologies Ltd Q4 FY2026 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/o53voz8br3jlcc5w2v44ihqy.pdf

Key Takeaways


Segment Performance

Lakshmana Rao: "On the contrary to your expectation, in fact, we are finding our clients coming back in herds because they are worried about the connectivity, material procurement abilities, and ability to quickly react to the international scenario."

Margin Drivers & Cost Headwinds

Lakshmana Rao: "So going forward with the only brownfield expansions, which will marginally may require capital, but increase in the capacity utilization will kick in. So I look at very positively for '26-'27 and to aim at least 42.5 to 43 range for '26-'27."

Capacity Expansion & Capex

Lakshmana Rao: "Be assured, we'll be widening our product range year after year and getting more and more deep into the Pharma sector in the coming years."

New Initiatives & Client Dynamics


ROCE Recovery Path

Lakshmana Rao: "That was when all these greenfield projects have been started, investments have shot up in the last 3 years. And these investments start yielding now. This year, I would say they crossed 50% to 60% capacity utilization. But next year onwards, I'm confident it will be 70% plus, and they will be yielding to the bottom line."

Guidance & Commitments

CommitmentSpecificsTimeline
RevenueCross ₹1,000 crFY27
Value growth13% to 15%FY27
Volume growth10% to 13%FY27
EBITDAAt least ₹210 cr (20% growth from ₹173 cr)FY27
EBITDA per kg42.5 to 43 rangeFY27
EBITDA per kg43 to 44 range; possibly 44-45 if Pharma performs wellFY28
ROCE13.5% to 14%FY27
ROCE~15%FY28
Pharma revenue₹50-55 cr (50% growth over FY26)FY27
Pharma capacityExpand from ~1,500 tons to 2,500 tonsFY27
Pharma new plantCommercial productionBeginning of calendar year 2027 (before end FY27)
Food & FMCG growthAt least 20% including NorthFY27
Panipat thin-wall utilizationFrom 20% to 40-50%FY27
ABG Panipat utilizationFrom ~60% to 70%+FY27
North plant new business₹35-40 cr from Qpack and Food combinedFY27
Vibe commercial revenueFirst revenueTowards end of FY27 (2-3 more quarters)
Capex₹80-85 cr, brownfield only, from internal accrualsFY27
DebtNo increase expectedFY27
Gross marginsMaintain 46-47% levelsFY27
RevenueEasily cross ₹1,200 cr (per an analyst's math, management said "I hope so")FY28

Key Metrics

MetricQ4 FY26
Revenue growth13.4% YoY for FY26
Pharma revenue₹34.4 cr for FY26, +219% YoY
Pharma revenue growth (Q4)+37% YoY
Paint segment value growth14.4% YoY
Paint segment volume growth13.5% YoY
Asian Paints growth (Q4)+17% YoY
ABG (Grasim) volume growth (Q4)+60% YoY
Food and FMCG growth>15% YoY
Qpacks growth25% YoY
IML mix (volume)75.5% in Q4, 75.13% for FY26
IML mix (value)76.8% for FY26
EBITDA per kg₹40.7 for FY26, up from ₹37.6, +8.4% YoY
EBITDA per kg guidance (FY27)₹42 to ₹43, aiming at 42.5
EBITDA guidance (FY27)At least ₹210 cr, up 20% from ₹173 cr in FY26
Total capacity63,000 MTPA, utilization ~43,000 tons
Capacity by end FY27~67,000 to 68,000 tons, possibly close to 70,000 tons
Capex FY26₹120 cr
Capex guidance FY27₹80 cr to ₹85 cr
Cash generation FY26~₹123 cr, net cash accruals ~₹100 cr after ~₹20 cr dividend
ROCE12.4% for FY26, up from 10.2%
ROCE guidance FY2713.5% to 14%
Raw material price (polypropylene)₹145 to ₹150/kg currently, from ₹105/kg in early March, peaked at ₹160/kg
Gross margin46% to 47%, maintained
Pharma capacity~1,500 tons, targeting 2,500 tons in FY27
Pharma volume FY26853 tons
Pharma volume guidance FY271,200 to 1,300 tons
Pharma revenue guidance FY27₹50 cr to ₹55 cr
Grasim (ABG) capacity12,000 tons (Panipat 5,000, Cheyyar 4,400, Mahad 2,500)
Grasim capacity utilization~65%, up from 50s last year
Panipat thin wall capacity utilization20% to 25%
Panipat thin wall capacity post July2,000 to 2,500 tons per annum including Qpack, doubling from ~1,000 tons
North plant (Qpack + Food) March sales~₹3 cr to ₹3.5 cr
North plant potential FY27 addition₹35 cr to ₹40 cr
Revenue guidance FY27₹1,000 cr+, 13% to 15% value growth
Volume growth guidance FY2710% to 13%
Lubes share of turnover17% to 18%
BPCL lost revenue>₹14 cr to ₹15 cr per year previously
Raw material inventory coverage~2 months